ÇѸ²´ëÇб³¼º½Éº´¿ø

±è¼º±Õ ±³¼ö

imnksk@hallym.or.kr
  • Àü¹®¼¾ÅÍ ECMO¼¾ÅÍ Àå±âÀ̽ļ¾ÅÍ
  • Áø·á°ú ½ÅÀå³»°ú

Àü¹®Áø·áºÐ¾ß

½ÅÀåÀ̽Ä, »ç±¸Ã¼½Å¿° (´Ü¹é´¢, Ç÷´¢), Ç÷¾×Åõ¼®, º¹¸·Åõ¼®

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2025-12-08 ~ 2025-12-13)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

ÇѸ²´ëÇб³ ÀÇÇÐ Á¹¾÷

¼º±Õ°ü´ëÇб³ ÀÇÇÐ ¼®»ç

¼­¿ï´ëÇб³ ÀÇÇÐ ¹Ú»ç

°æ·Â

°æ·Â

°­µ¿¼º½Éº´¿ø ÀÎÅÏ

°­µ¿¼º½Éº´¿ø ³»°ú Àü°øÀÇ

¼­¿ï´ëÇб³º´¿ø ½ÅÀå³»°ú ÀÓ»ó°­»ç

ÇѸ²´ëÇб³¼º½Éº´¿ø ½ÅÀå³»°ú ºÐ°úÀå

ÇѸ²´ëÇб³¼º½Éº´¿ø ¼ö·Ã±³À°ºÎÀå

ÇѸ²´ëÇб³¼º½Éº´¿ø Áø·áºÎ¿øÀå

ÇѸ²´ëÇб³¼º½Éº´¿ø ½ÅÀå³»°ú ±³¼ö

ÇѸ²½Ã¹Ä·¹À̼Ǽ¾ÅÍ ¼¾ÅÍÀå ¹× ¿î¿µÀ§¿øÈ¸ À§¿øÀå

ÇѸ²´ëÇб³ÀÇ·á¿ø ºÎÀÇ·á¿øÀå

2018 ´ëÇÑÁßÀç½ÅÀåÇבּ¸È¸ Ãѹ«ÀÌ»ç

2017- ÇöÀç ±ÙÀ°°¨¼ÒÁõ ¹× ¿©¸²¿¡ °üÇÑ ¿¬±¸È¸ Ãѹ«ÀÌ»ç

2019- ÇöÀç ´ëÇÑÁßÀç½ÅÀåÇבּ¸È¸ ȸÀå

ÇÐȸȰµ¿

ÇÐȸȰµ¿

¹Ì±¹ÀÇ·á½Ã¹Ä·¹À̼ÇÇÐȸ(SSH), ¹Ì±¹ÁßÀç½ÅÀåÇÐȸ(ASDIN) Á¤È¸¿ø

´ëÇѳ»°úÇÐȸ Á¤È¸¿ø

´ëÇѽÅÀåÇÐȸ Á¤È¸¿ø

Çѱ¹»ý¸íÀ±¸®ÇÐȸ Á¤È¸¿ø

¹Ì±¹½ÅÀåÇÐȸ(ASN), ±¹Á¦º¹¸·Åõ¼®ÇÐȸ(ISPD) Á¤È¸¿ø

³í¹®

Editorial Expression of Concern: Development of deep learning algorithm for detecting dyskalemia based on electrocardiogram(Scientific Reports, 10.1038/s41598-024-71562-5) (Scientific Reports)

Self-Assessment of acute rib fracture detection system from chest X-ray: Preliminary study for early radiological diagnosis (JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY)

Galectin-3 as a prognostic biomarker in haemodialysis patients with preserved or mildly reduced ejection fraction (Clinical Kidney Journal)

Immunogenicity and Breakthrough Outcomes of mRNA Booster Strategies Among Healthcare Workers During the BA.1/BA.2 Omicron Surge (MICROORGANISMS)

Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathy (Kidney International)

Unmet clinical need in patients with acute kidney injury and acute kidney disease: insights from a Korean multicenter cohort (KIDNEY RESEARCH AND CLINICAL PRACTICE)

Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy (JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY)

Efficacy and Safety of Ravulizumab in IgA Nephropathy A Phase 2 Randomized Double-Blind Placebo-Controlled Trial (Journal of the American Society of Nephrology)

Impact of Peritoneal Neutrophil Extracellular Traps on Peritoneal Characteristics and Technical Failure in Patients Undergoing Peritoneal Dialysis (AMERICAN JOURNAL OF NEPHROLOGY)

Study protocol for a consortium linking health medical records, biospecimens, and biosignals in Korean patients with acute kidney injury (LINKA cohort) / ^^¿µ¹® Á¦¸ñÀ» ¹Ýµå½Ã ±âÀçÇϽñ⠹ٶø´Ï´Ù. (Kidney research and clinical practice)
ÀÓ»ó½ÅÀåÇÐ / Clinical Nephrology (±ºÀÚÃâÆÇ»ç)

¸¸¼º ÄáÆÏº´, Çϳª¿¡¼­ ¿­°¡Áö (IMED KOREA)

¸¸¼º ÄáÆÏº´, Çϳª¿¡¼­ ¿­±îÁö (IMED Korea)

Àü°øÀǸ¦ À§ÇÑ ½ÅÀå³»°ú ¸Å´º¾ó / Manual of Nephrology (ÇѸ²´ëÇб³ ÃâÆÇºÎ)

(ÀÓ»ó)³»°úÇÐ (°í·ÁÀÇÇÐ)

ÀÓ»ó½ÅÀåÇÐÀÔ¹® ((ÁÖ)½ÅÈï¸Þµå»çÀ̾ð½º)

°Ç°­¸Å°ÅÁø